ENTERO vs OSIAHYPER: Stock Comparison
ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows faster revenue growth, lower leverage and a higher net margin, while OSIAHYPER shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ENTERO leads 8; OSIAHYPER leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ENTERO | OSIAHYPER |
|---|---|---|
| Sector | Consumer Services | Consumer Services |
| Industry | Pharmacy Retail | Diversified Retail |
Price
| Metric | ENTERO | OSIAHYPER |
|---|---|---|
| Live Price | ₹1,797.4 | ₹5.61 |
| Day Change | -0.42% | -4.92% |
| Volume | 1.67 L | 2.3 L |
| 52-Week High | ₹1,841.5 | ₹19.91 |
| 52-Week Low | ₹944 | ₹3.19 |
| Distance from 52W High | -2.39% | -71.82% |
Valuation
| Metric | ENTERO | OSIAHYPER |
|---|---|---|
| Market Cap | ₹7,834 Cr | ₹44 Cr |
| P/E Ratio | 62.47x | 7.67x |
| P/B Ratio | 4.64x | 0.3x |
| EPS | ₹28.78 | ₹0.24 |
| Book Value | ₹388.09 | ₹22.18 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ENTERO | OSIAHYPER |
|---|---|---|
| Revenue Growth (TTM YoY) | 42.6% | 0% |
| EPS Growth (TTM YoY) | 9.1% | 0% |
| Qtr Sales Growth | 2,230.48% | 2.66% |
| Qtr Profit Growth | 1,405.67% | -15.38% |
Profitability & Leverage
| Metric | ENTERO | OSIAHYPER |
|---|---|---|
| ROE | 1.6% | 4.58% |
| ROCE | 2.01% | 6.66% |
| Net Margin | 1.75% | 1.37% |
| Operating Margin | 9.99% | 3.55% |
| Debt to Equity | 0.06x | 0.46x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ENTERO | OSIAHYPER |
|---|---|---|
| Promoter Holding | 14.4%▼ 0.01 pp | 33.86%▼ 12.76 pp |
| FII Holding | 4.37%▲ 0.34 pp | 0.47%▲ 0.34 pp |
| DII Holding | 15.48%▼ 1.14 pp | 0% |
| Public Holding | 27.75%▲ 0.82 pp | 65.68%▲ 12.43 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and OSIAHYPER.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.